Mesoblast stem cell therapy approved by Japanese health watchdog – Sydney Morning Herald
Sydney Morning Herald |
Mesoblast stem cell therapy approved by Japanese health watchdog
Sydney Morning Herald Mesoblast has won full regulatory approval for its first stem cell therapy from the Japanese health regulator, paving the way for the biotechnology company to receive royalties to fund expensive clinical trials. On Friday the Japanese Ministry of … Full Product Approval In Japan Received By Mesoblast Licensee |
